# Efthalia Angelopoulou

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/efthalia-angelopoulou/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,617 |
| Field | Parkinson's Disease Mechanisms and Treatments |
| h-index | 34 |
| i10-index | 75 |
| Last Known Institution | National and Kapodistrian University of Athens |
| OpenAlex ID | https://openalex.org/A5030161367 |
| ORCID iD | 0000-0002-1426-3384 |
| Works | 132 |

## Researcher papers

- [Revisiting the role of neurotransmitters in epilepsy: An updated review](https://scholariq.org/papers/revisiting-the-role-of-neurotransmitters-in-epilepsy-an-updated-review/)
- [Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting](https://scholariq.org/papers/impact-of-hmgb1-rage-and-tlr4-in-alzheimer-s-disease-ad-from-risk-factors-to/)
- [Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling](https://scholariq.org/papers/enlightening-the-role-of-high-mobility-group-box-1-hmgb1-in-inflammation-updates/)
- [miR-124 and Parkinson’s disease: A biomarker with therapeutic potential](https://scholariq.org/papers/mir-124-and-parkinson-s-disease-a-biomarker-with-therapeutic-potential/)
- [Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk](https://scholariq.org/papers/emerging-neuroprotective-effect-of-metformin-in-parkinson-s-disease-a-molecular/)
- [HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic Opportunities](https://scholariq.org/papers/hmgb1-mediated-neuroinflammatory-responses-in-brain-injuries-potential/)
- [Potential Neuroprotective Effect of the HMGB1 Inhibitor Glycyrrhizin in Neurological Disorders](https://scholariq.org/papers/potential-neuroprotective-effect-of-the-hmgb1-inhibitor-glycyrrhizin-in/)
- [APOE Genotype and Alzheimer’s Disease: The Influence of Lifestyle and Environmental Factors](https://scholariq.org/papers/apoe-genotype-and-alzheimer-s-disease-the-influence-of-lifestyle-and/)
- [Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders](https://scholariq.org/papers/neuroprotective-potential-of-chrysin-mechanistic-insights-and-therapeutic/)
- [Neuroprotective potential of chrysin in Parkinson's disease: Molecular mechanisms and clinical implications](https://scholariq.org/papers/neuroprotective-potential-of-chrysin-in-parkinson-s-disease-molecular-mechanisms/)
- [Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review](https://scholariq.org/papers/environmental-impact-on-the-epigenetic-mechanisms-underlying-parkinson-s-disease/)
- [Ambiental Factors in Parkinson’s Disease Progression: A Systematic Review](https://scholariq.org/papers/ambiental-factors-in-parkinson-s-disease-progression-a-systematic-review/)

## Researcher topics

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Neuroinflammation and Neurodegeneration Mechanisms](https://scholariq.org/topics/neuroinflammation-and-neurodegeneration-mechanisms/)

## Researcher university

- [National and Kapodistrian University of Athens](https://scholariq.org/institutions/national-and-kapodistrian-university-of-athens/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.